Related Experiment Video

Updated: Aug 24, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Evolution of paediatric oncology over the years: overview with a focus on sub-Saharan Africa and examples from the

E G Kasili1

  • 1Department of Haematology, College of Health Sciences, University of Nairobi, Kenya.

East African Medical Journal
|June 1, 1993
PubMed

Insights

Paediatric oncology has evolved globally, improving childhood cancer treatment and influencing adult cancer care. Challenges in developing countries, like establishing units in Kenya, are highlighted using Burkitt's lymphoma as a case study.

Area of Science:

  • Oncology
  • Global Health
  • Medical History

Background:

  • The paper traces the historical development of paediatric oncology as a global subspecialty.
  • It emphasizes the crucial role of paediatric oncology units in advancing childhood cancer management.
  • The progress in adult cancer treatment is noted to be influenced by breakthroughs in paediatric oncology.

Observation:

  • Childhood cancer epidemiology in sub-Saharan Africa is examined.
  • The establishment and growth of paediatric oncology units, specifically at Kenyatta National Hospital in Nairobi, Kenya, are detailed.
  • Challenges, constraints, and successes in developing paediatric oncology services in resource-limited settings are discussed.

Findings:

  • The evolution of paediatric oncology units has significantly contributed to improved outcomes in childhood cancer.
  • Developing countries face unique hurdles in establishing and sustaining paediatric oncology care.
  • Burkitt's lymphoma serves as an illustrative example of the complexities in paediatric cancer management in sub-Saharan Africa.

Implications:

  • Understanding the historical trajectory of paediatric oncology is vital for future advancements.
  • Addressing challenges in developing nations is crucial for equitable access to childhood cancer care.
  • The successes and challenges in establishing paediatric oncology units offer valuable lessons for other low- and middle-income countries.

Keywords:
AfricaAfrica South Of The SaharaAge FactorsCancerChild HealthDelivery Of Health CareDemographic FactorsDeveloping CountriesDiseasesEastern AfricaEnglish Speaking AfricaHealthHealth FacilitiesHistorical SurveyHospitalsKenyaNeoplasmsObstaclesOrganization And AdministrationPopulationPopulation CharacteristicsProgram DevelopmentProgramsTreatment

More Related Videos

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...